Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 133 record(s)

Req # A-2021-00001

Copies of all meeting minutes, presentations and speaking notes associated with the following 2018 meetings of the PMPRB Steering Committee on Modernization of Price Review Process Guidelines and the working group struck to inform that committee: July 26, August 15, August 22, August 24, September 12, September 25, October 12 and December 13.

Organization: Patented Medicine Prices Review Board Canada

154 page(s)
December 2021

Req # A-2021-10639

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and The Best Medicines Coalition over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

14 page(s)
December 2021

Req # A-2021-10640

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and The Canadian Generic Pharmaceutical Association over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

25 page(s)
December 2021

Req # A-2021-10643

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Biosimilars Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

21 page(s)
December 2021

Req # A-2021-10644

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and The Canadian Organization for Rare Disorders (CORD) over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

26 page(s)
December 2021

Req # A-2021-10656

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and The Neighbourhood Pharmacy Association of Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
December 2021

Req # A-2021-10676

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PDCI Market Access over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

5 page(s)
December 2021

Req # A-2021-10684

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and GlaxoSmithKline Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
December 2021

Req # A-2021-10689

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Janssen over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

3 page(s)
December 2021

Req # A-2021-10696

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Lundbeck Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 10, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
December 2021
Date modified: